Solutions > High cost specialty market
Special Drug Tracking
Monitor special drugs focusing on the indication of each product
Solutions > High cost specialty market
Special Drug Tracking
Monitor special drugs focusing on the indication of each product
Evaluation of market share of the high cost specialty market based on the product indication, molecule and brand in the channel- Assessment of the promotional point of sale and behavior in oncology, hematology, virology, central nervous system, rare diseases, vaccinations and rheumatology markets
- Access to account management indicators: clients, product, market share and current and future opportunities to be explored
Special Drug Tracking (SDT) is the only report in Latin America that allows clients to evaluate the high cost specialty market
- Accesses a reliable sample at national level based on the relevance of major institutions and physicians
- Operates with data obtained by indication and other relevant variables, such as drug sequencing, treatment time, institutional environment, treatment line, market share, market growth and penetration by product indication and analysis of the treatment line, among others
- Accesses the treatment consumer identification in every institution, either private or public, providing detailed information about private consumers
- Performs an analytical interpretation of data that integrates with clients’ plans, strategies and tactics.
- Evaluates total market potential by indication up to the treatment level (market dimensioning).